Quick Summary
PEG L-Aspatero 3750IU Injection
Last updated on 31 Mar 2026 | 09:31 AM (IST)
₹19267
MRP: ₹26329.69
(You Save ₹7062.69)
1 VIAL(s) OF 5ML
PEG L-Aspatero 3750IU Injection
Salt Composition
PEG L-ASPARAGINASEMarketer
HETERO HEALTHCARE LTD
Prepaid Only. Non-Returnable.
27% OFF
₹19267
MRP: ₹26,329.69
Inclusive of all taxes
27% Off
Salt Composition
PEG L-ASPARAGINASEMarketer
HETERO HEALTHCARE LTD
Prepaid Only. Non-Returnable.
Dispatch: Today
Order In: 0h 0m 0s
0h 0m 0s
Order before timer ends to ensure your medicine is dispatched at...
Substitutes
Lagipeg 3750IU Injection
CADILA PHARMACE...
₹ 16160.00/injection
16% cheaper
Pegizex 3750IU Injection
HALSTED PHARMA ...
₹ 19119.00/injection
0% cheaper
Peglasp 3750IU Injection
METTA LIFE SCIE...
₹ 19894.00/injection
4% costlier
Mejorasp 3750IU Injection
SAYRE THERAPEUT...
₹ 22907.00/injection
19% costlier
Introduction to PEG L-Aspatero 3750IU Injection
Peg L-Aspatero 3750IU Injection contains Peg-L-asparaginase. It is used to treat Acute Lymphoblastic Leukemia (cancer of white blood cells) in patients aged four months and above. In Acute Lymphoblastic Leukemia, the white blood cells called lymphocytes multiply uncontrolled and abnormally. This disorder is also known as Acute Lymphocytic Leukemia.
This medicine should not be used if you have severe problems with your pancreas or are allergic to asparaginase or any of the ingredients of this medicine. Talk to your physician if you are a diabetic patient, as this medicine contains glucose. The common side effects of Peg L-Aspatero 3750IU Injection are muscle pain, nausea, infections, abdominal pain, and diarrhea.
Use effective birth control during the treatment with Peg L-Aspatero 3750IU Injection and for at least three months after the last dose. Women should use contraception methods other than oral contraceptives.
Uses of PEG L-Aspatero 3750IU Injection
- Acute Lymphoblastic Leukemia (ALL)
Therapeutic Effects of PEG L-Aspatero 3750IU Injection
Cancer cells need a substance called asparagine to survive. Peg L-Aspatero 3750IU Injection works by lowering the levels of asparagine in the body.
Interaction of PEG L-Aspatero 3750IU Injection with other drugs
Inform your doctor about any prescribed medications, over-the-counter medicines, nutritional or vitamin supplements, and herbal products you take or have taken before the treatment. Certain medications may interact with Peg L-Aspatero 3750IU and can cause undesirable side effects.
More Information about PEG L-Aspatero 3750IU Injection
- Keep Peg L-Aspatero 3750IU Injection out of sight and reach of children.
- Store in a refrigerator (2°C to 8°C).
How to consume PEG L-Aspatero 3750IU Injection
It will be given to you by your healthcare professional. Your doctor will decide the dose and dosage of your treatment based on the disease condition and other factors. Do not self-administer.
Safety Advice for PEG L-Aspatero 3750IU Injection
Breast Feeding
You must not breastfeed your baby during treatment with Peg L-Aspatero 3750IU Injection. You need to tell your physician if you are breastfeeding before taking this medicine.
Alcohol
It is unknown whether it is safe to consume alcohol while taking Peg L-Aspatero 3750IU. Inform your physician if you are a chronic drinker.
Liver
You need to tell your physician if you have any liver disorders before taking Peg L-Aspatero 3750IU Injection.
Lungs
Limited information is available on the safety of Peg L-Aspatero 3750IU in patients with lung problems. Inform your physician if you have lung disease or disorders before initiating the treatment.
Driving
Peg L-Aspatero 3750IU Injection can cause dizziness and drowsiness. Avoid driving if you are unwell.
Pregnancy
You should not take Peg L-Aspatero 3750IU if you are pregnant or planning to get pregnant because it may cause birth defects.
Side Effects of PEG L-Aspatero 3750IU Injection
Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them.
Serious
- Severe allergic reactions
- High blood sugar levels
- Bleeding
- Liver and nervous problems
- Pain near your stomach (inflammation of the pancreas)
- Blood clots in arm or leg
- Pain, bruising, swelling, or hardening of the skin at the injection site
Common
- Nausea
- Muscle pain
- Weight loss
- Infections (fever, rapid heart rate, confusion, or a rash)
- Difficulty breathing
- Inflammation of the digestive tract
- Diarrhea
- Abdominal pain, discomfort
- Headache
- Tiredness
Word of Advice
This injection should be administered only by the doctor or nurse. Inform the doctor if the patient has any allergic response, blood pressure, kidney or liver problems, and medication taken for different medical conditions. Consult the doctor if the patient is pregnant or breastfeeding mother before taking this medication. Avoid driving while taking this medication, as it can cause dizziness. Avoid handling heavy machinery as the patient may lack concentration.
FAQs about PEG L-Aspatero 3750IU Injection
Q1.
Can Peg L-Aspatero 3750IU Injection affect blood glucose levels?
Yes, Peg L-Aspatero 3750IU medication can increase blood glucose levels as it contains glucose. Blood glucose levels should be monitored regularly while taking this medication.
Q2.
Can Peg L-Aspatero 3750IU Injection be self administered?
No, Peg L-Aspatero 3750IU injection should be administered only by the doctor or nurse and should not be self administered. Wrong injection techniques can lead to complications.
Q3.
Can I use Peg L-Aspatero 3750IU Injection while driving?
Avoid driving and handling heavy machineries while taking Peg L-Aspatero 3750IU medication, as it causes dizziness and lack of concentration.
Q4.
Is it safe to use Peg L-Aspatero 3750IU Injection during breastfeeding?
It is unsafe to use this medication during breastfeeding, and inform the doctor before taking Peg L-Aspatero 3750IU medication.
Q5.
Is Peg L-Aspatero 3750IU a chemotherapy medication?
Yes, it is a chemotherapy medicine which is used to treat Acute Lymphoblastic Leukemia (cancer of white blood cells).
Fact Box of PEG L-Aspatero 3750IU Injection
Molecule name: Peg-L-Asparaginase | Therapeutic class: Anti-neoplastics |
| Pharmacological Class: Enzyme | Indications: Acute Lymphoblastic Leukemia (ALL) |
References
- Goodman & Gilman’s, The Pharmacological Basis of Therapeutics, Cytotoxic agents, 12th edition, 2011, 1720.
- KD Tripathi, Essentials of Medical Pharmacology, Anticancer drugs, 7th edition, 2013, 869.
- Porton Biopharma Limited, Electronic medicines compendium (emc), [Revised on June 2021] [ Accessed on 9th August 2021], https://www.medicines.org.uk/emc/files/pil.12340.pdf
- Merck & Co., Inc., US Food and Drug Administration, [Issued on 2000] [ Accessed on 5th August 2021], https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/aspamer080102LB.pdf
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
Did you find this information helpful?
Author Details
Written By
Aswini Priya Velmurugan
PG in Biotechnology
Reviewed By
Dr. Tejashwin Adiga
MBBS
Last updated : 31 Mar 2026 | 09:31 AM (IST)
Want to know more?
Read Our Editorial Policy
